Home › Idiopathic Thrombocytopenic Purpura › New York
Pag-aaral pangklinika para sa Idiopathic Thrombocytopenic Purpura sa New York
7 pag-aaral para sa Idiopathic Thrombocytopenic Purpura ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Montefiore Medical Center, The Bronx
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07421167A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06722235Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Montefiore Medical Center, The Bronx
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07104565A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- NY Cancer and Blood Specialists, Shirley
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06948318Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- New York Oncology Hematology-Investigational Site Number: 8400010, Albany
- Montefiore Medical Center-Investigational Site Number: 8400012, The Bronx
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT07007962Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
- New York Medical College, Vahalla
Nagre-recruitPhase 1
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04323748Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.